CUHK Develops Microrobots To Speed Up Medical Test

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1442669_1_20190213182235.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1442669-20190213.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1442669-20190213.htm', 'DCS.dcsqry', '' ); } } }); }); });

2019-02-13 HKT 18:22

Share this story

facebook

  • Researchers say their new microrobots will drastically cut down the time it takes to check whether patients have a C difficile infection. Photo: RTHK

    Researchers say their new microrobots will drastically cut down the time it takes to check whether patients have a C difficile infection. Photo: RTHK

Experts at Chinese University have developed a new test using microscopic robots that they say can diagnose people suffering from a deadly type of gastrointestinal infection known as Clostridium Difficile, in a fraction of the time that current tests take.

C difficile infections are very common – especially among elderly patients and the chronically ill – and can prove fatal in extreme cases. Patients typically have symptoms such as diarrhoea and fever, and doctors need to identify whether patients are in fact infected with this particular type of bacteria before they can start treatment.

The problem is, patients have to undergo two sets of tests that can take as long as two days – a delay that doctors say is not ideal.

But experts at Chinese University say microrobots smaller than a red blood cell, made from plant spores, can cut that time down to 15 minutes.

The microrobots have carbon dots on them, that are fluorescent. But if they're mixed in with stool samples that contain toxins produced by C difficile, their fluorescence declines.

Professor Joseph Sung from the university's faculty of medicine said this new test isn't just quick, it is more accurate.

"The advantage of this test is that it can skip the two-step approach that we currently use for the diagnosis of C difficile diarrhoea," Sung said.

The Faculty of Engineering's Professor Zhang Li, who developed the microrobots, said they could be used to identify other pathogens in future.

The university said it will conduct more clinical trials this year before deciding when to officially introduce the new test.

RECENT NEWS

TOPPAN Edge And Partisia Partner For Fully Privacy-Focused Digital Identity Solution

TOPPAN Edge is partnering with Partisia to develop a fully privacy-focused digital identity using Partisia’s Decentr... Read more

Livi Bank Achieves HKD2.9B In Customer Deposit Growth

livi Bank reported a total operating income of HK$220 million in 2024 in its latest annual report results, marking a 76... Read more

OSL And Ant Digital Partner To Drive Real-World Asset Tokenisation

OSL Group (863.HK), a publicly listed company for digital assets, and Ant Digital Technologies signed a Memorandum of U... Read more

WeLab Bank Hits Profit In 2025 With HKD750M Revenue

WeLab Bank achieved profitability in Q1 2025*, continuing from 2024 when it achieved breakeven within four years of its... Read more

Adoption Of GenAI Rises In Hong Kongs Financial Sector, Though Focus Remains On Internal Operations

In Hong Kong, financial institutions are increasingly adopting generative artificial intelligence (genAI), aiming for e... Read more

HKMA Forms CargoX Expert Panel To Modernise Trade Finance

On 28 April 2025, the Hong Kong Monetary Authority (HKMA) announced the creation of an Expert Panel on Project Cargox. ... Read more